文献速递肝病

肝硬化患者左心室收缩功能与交感神经活性及炎症标志物相关

Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis.
PubMed 文献 · Hepatology · 2017-04-28

研究纳入59例肝硬化患者和59例年龄匹配对照,用超声心动图指标评估左心室收缩功能及其与交感神经激活和炎症的关系,并对11例患者进行干预亚研究。结果显示肝硬化患者收缩功能指标高于对照,且与肝病严重程度、交感激活及β受体阻滞剂治疗相关;急性后负荷应激对血管扩张和炎症更明显者的收缩功能抑制更深。

要点

  • 肝硬化患者左心室收缩功能指标EIVPD和收缩应变率高于年龄匹配对照。
  • EIVPD与MELD评分、去甲肾上腺素、心率变异性及β受体阻滞剂治疗相关。
  • 急性后负荷应激下,基线收缩功能较好者EIVPD下降更明显,且与血管扩张和炎症标志物相关。

核心结论

  • 肝硬化时左心室收缩功能因肾上腺素能张力增强而增强,并受β受体阻滞剂治疗调节。
  • 急性后负荷应激在血管扩张和炎症更明显的患者中诱导更深的收缩功能损害。
  • 这些与肝硬化相关的左心室功能变化可用稳健的超声心动图方法评估。

研究设计与样本

  • 研究纳入59例肝硬化患者和59例年龄匹配对照,进行超声心动图评估。
  • 另在11例患者中撤除β受体阻滞剂和利尿剂,使用去氧肾上腺素和白蛋白输注评估急性后负荷和前负荷变化的反应(干预亚研究)。

主要发现

  • 肝硬化患者EIVPD中位数4.0(1st-3rd四分位3.1-5.1)mm Hg vs 对照2.9(2.4-3.6)mm Hg,收缩应变率中位数-1.3(-1.6至-1.1)s-1 vs 对照-1.2(-1.6至-1.1)s-1,两者P均<0.05。
  • EIVPD与MELD评分相关(rho=0.45,P<0.001),与去甲肾上腺素相关(rho=0.26,P=0.05),与心率变异性相关(rho=-0.43,P=0.003),与β受体阻滞剂治疗相关(P=0.001)。
  • 干预亚研究中,有腹水患者EIVPD高于无腹水患者(6.5[5.4-8.5] vs 4.0[3.9-5.1] mm Hg,P=0.045)。
  • 去氧肾上腺素诱导的EIVPD下降与基线收缩功能呈负相关(P<0.05),与一氧化氮相关(rho=-0.66,P=0.06),与舒张压相关(rho=0.68,P=0.04),与白介素-1β相关(rho=-0.80,P=0.009)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: An accurate evaluation of cardiac function in patients with cirrhosis remains a challenge. We used robust echocardiographic indices to characterize left ventricular (LV) systolic function and its relationship to activation of the sympathetic nervous system and inflammation in 59 patients with cirrhosis and 59 age-matched controls. Additionally, in 11 patients we withdrew beta-blockers and diuretics and used phenylephrine and albumin infusion to evaluate the response to acute afterload and preload changes (interventional substudy). Measures of systolic LV function such as the ejection intraventricular pressure difference (EIVPD) and the systolic strain rate were higher in patients with cirrhosis than in controls (median [1st-3rd quartile], 4.0 [3.1-5.1] versus 2.9 [2.4-3.6] mm Hg and -1.3 [-1.6 to -1.1] versus -1.2 [-1.6 to -1.1)] s-1 , respectively; P < 0.05 for both). EIVPD was related to the severity of liver disease (Model for End-Stage Liver Disease, rho = 0.45, P < 0.001), the degree of sympathetic nervous system activation (noradrenaline, rho = 0.26, P = 0.05; heart rate variability, rho = -0.43, P = 0.003), and treatment with beta-blockers (P = 0.001). In the interventional substudy, EIVPD was higher in patients with ascites (6.5 [5.4-8.5] versus 4.0 [3.9-5.1] mm Hg, P = 0.045). The decrease in EIVPD induced by phenylephrine was inversely related to baseline systolic function (P < 0.05) and associated with markers of systemic vasodilatation (nitric oxide, rho = -0.66, P = 0.06; diastolic blood pressure, rho = 0.68, P = 0.04) and inflammation (interleukin-1beta, rho = -0.80, P = 0.009). CONCLUSION: LV systolic function is enhanced in cirrhosis due to augmented adrenergic tone and modulated by treatment with beta-blockers; acute afterload stress induces a deeper impairment of systolic function in patients with more advanced degrees of vasodilatation and inflammation; these changes in LV function related to cirrhosis can be assessed using robust echocardiographic methods. (Hepatology 2017;65:2019-2030).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Yotti R, Ripoll C, Benito Y, et al. Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis. Hepatology. 2017. PMID: 28195341. doi:10.1002/hep.29104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。